A case of Alemtuzumab-induced neutropenia in multiple sclerosis in association with the expansion of large granular lymphocytes

BACKGROUND: Alemtuzumab has been demonstrated to reduce the risks of relapse and accumulation of sustained disability in Multiple Sclerosis (MS) patients compared to β-interferon. It acts against CD52, leading primarily to lymphopenia. Recent data have shown that mild neutropenia is observed in 16%...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:BMC Neurol
Main Authors: Vakrakou, A. G., Tzanetakos, D., Valsami, S., Grigoriou, E., Psarra, K., Tzartos, J., Anagnostouli, M., Andreadou, E., Evangelopoulos, M. E., Koutsis, G., Chrysovitsanou, C., Gialafos, E., Dimitrakopoulos, A., Stefanis, L., Kilidireas, C.
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2018
Fag:
Case Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6206708/
https://ncbi.nlm.nih.gov/pubmed/30373566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-018-1183-4
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker